<DOC>
	<DOCNO>NCT01356394</DOCNO>
	<brief_summary>Metabolic syndrome ( MS ) cluster risk factor cardiovascular disease ( CVD ) hypertension , hypertriglyceridemia , low HDL-cholesterol level , disorder glucose metabolism , insulin resistance . A number associate condition include MS spectrum abdominal obesity , systemic inflammatory activation , endothelial dysfunction , non-alcoholic fatty liver disease , hyperuricemia , polycystic ovarian syndrome , microalbuminuria . As consequence , diagnosis MS identify patient increase risk type 2 diabetes mellitus CVD . In last year , potential MS trigger renal damage accelerate progression pre-existing nephropathy become focus research . Some study suggest MS influence development CKD , although underlying mechanism well understood . In study , investigator hypothesize modify key component MS , namely obesity , could attenuate renal damage . The investigator examine impact weight loss creatinine clearance urinary albumin excretion non-diabetic obese patient MS .</brief_summary>
	<brief_title>Weight Loss Improves Renal Hemodynamics</brief_title>
	<detailed_description>Non-diabetic patient MS recruit outpatient clinic Division Nephrology Federal University Juiz de Fora , Brazil . MS define accord criterion National Cholesterol Education Program Adult Treatment Panel III ( NCEP-ATPIII ) . The study divide two phase : phase 1 ( baseline ) phase 2 ( intervention ) . At first study visit , full medical history take clinical examination perform . Blood sample take determine plasma glucose level , fast 2 h 75-g oral glucose overload ( oral glucose tolerance test ; OGTT ) , well level plasma insulin , creatinine , total cholesterol , HDL-cholesterol , triglyceride , uric acid . At visit 2 , preliminary result evaluate urine sample collect duplicate measurement microalbuminuria . Creatinine clearance estimate use Cockcroft-Gault formula , correct body surface area . The subject keep free medication ( statin , antihypertensive , anti-inflammatory drug ) entire study period . The medication allow study analgesic dipyrone hioscin . At visit 3 , patient evaluate registered dietitian expertise medical nutrition therapy aim achieve weight loss least 5 % baseline . Patients commence 12-week calorie-restricted diet consist 50 % carbohydrate , 20-25 % protein , 25-30 % fat . The patient evaluate dietitian every 2 week . At final visit laboratory test repeat . At end phase 2 , patient divide two group : responder , achieve least 5 % reduction body weight non-responders , achieve target weight reduction .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Male female Age : 20 65 year old Metabolic syndrome accord criterion National Cholesterol Education Program Adult Treatment Panel III fast plasma glucose &gt; 126 mg/dL history diabetes mellitus hypertension stage 2 3 glomerulonephritis CKD stag 3 , 4 , 5 severe heart lung disease pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Metabolic Syndrome</keyword>
	<keyword>Microalbuminuria</keyword>
	<keyword>Chronic Kidney Disease</keyword>
</DOC>